BACKGROUND: Rectal cancer seriously threats to human health. Traditional chemotherapy drugs might kill rectal cancer cells while easy cause side effects and clinical complications. Therefore, it is necessary to explore possible new methods for rectal cancer treatment. Survivin is an important tumor-specific protein. Previous researches showed it may be closely related to nasopharyngeal carcinoma. Its role in rectal cancer remains unclear. METHODS: Cultivate human rectal cancer HRC-9698 cells. Antisense microRNA targeting survivin and control miRNA were constructed and transfected to HRC-9698 cells. MTT assay was applied to detect cell growth. Flow cytometry was used to test cell apoptosis. Western blot was performed to detect Osteopontin expression level. Colony formation and transwell assay were used to test cell clone formation and invasion abilities. RESULTS: Antisense microRNA targeting survivin can inhibit HRC-9698 cell proliferation and induce its apoptosis. Antisense microRNA targeting survivin decreased osteopontin expression level. Overexpressed osteopontin inhibited antisense microRNA targeting survivin induced cell apoptosis. Antisense microRNA targeting survivin suppressed HRC-9698 cells' colony formation and invasion abilities. CONCLUSION: Antisense microRNA targeting survivin induced osteopontin participated HRC-9698 cell apoptosis. Antisense microRNA targeting survivin inhibited HRC-9698 cell colony formation and invasive abilities, indicating that survivin may play its anti-tumor effect through inducing cell apoptosis and inhibiting cell metastasis and invasion.
BACKGROUND:Rectal cancer seriously threats to human health. Traditional chemotherapy drugs might kill rectal cancer cells while easy cause side effects and clinical complications. Therefore, it is necessary to explore possible new methods for rectal cancer treatment. Survivin is an important tumor-specific protein. Previous researches showed it may be closely related to nasopharyngeal carcinoma. Its role in rectal cancer remains unclear. METHODS: Cultivate humanrectal cancerHRC-9698 cells. Antisense microRNA targeting survivin and control miRNA were constructed and transfected to HRC-9698 cells. MTT assay was applied to detect cell growth. Flow cytometry was used to test cell apoptosis. Western blot was performed to detect Osteopontin expression level. Colony formation and transwell assay were used to test cell clone formation and invasion abilities. RESULTS: Antisense microRNA targeting survivin can inhibit HRC-9698 cell proliferation and induce its apoptosis. Antisense microRNA targeting survivin decreased osteopontin expression level. Overexpressed osteopontin inhibited antisense microRNA targeting survivin induced cell apoptosis. Antisense microRNA targeting survivin suppressed HRC-9698 cells' colony formation and invasion abilities. CONCLUSION: Antisense microRNA targeting survivin induced osteopontin participated HRC-9698 cell apoptosis. Antisense microRNA targeting survivin inhibited HRC-9698 cell colony formation and invasive abilities, indicating that survivin may play its anti-tumor effect through inducing cell apoptosis and inhibiting cell metastasis and invasion.
Authors: Wolfgang Eisterer; Alexander De Vries; Dietmar Öfner; Hans Rabl; Renate Koplmüller; Richard Greil; Jöerg Tschmelitsch; Rainer Schmid; Karin Kapp; Peter Lukas; Felix Sedlmayer; Gerald Höfler; Michael Gnant; Josef Thaler Journal: Anticancer Res Date: 2014-11 Impact factor: 2.480
Authors: Claudio V Sole; Felipe A Calvo; Emilio Alvarez; Isabel Peligros; Pilar Garcia-Alfonso; Carlos Ferrer; Enrique Ochoa; Rafael Herranz; Jose L Carreras Journal: Eur J Nucl Med Mol Imaging Date: 2013-06-26 Impact factor: 9.236
Authors: Wissam A Aboualaiwi; Brian S Muntean; Shobha Ratnam; Bina Joe; Lijun Liu; Robert L Booth; Ingrid Rodriguez; Britney S Herbert; Robert L Bacallao; Marcus Fruttiger; Tak W Mak; Jing Zhou; Surya M Nauli Journal: Circulation Date: 2013-11-14 Impact factor: 29.690
Authors: Max Leenders; Anke M Leufkens; Peter D Siersema; Fränzel J B van Duijnhoven; Alina Vrieling; Paul J M Hulshof; Carla H van Gils; Kim Overvad; Nina Roswall; Cecilie Kyrø; Marie-Christine Boutron-Ruault; Guy Fagerhazzi; Claire Cadeau; Tilman Kühn; Theron Johnson; Heiner Boeing; Krasimira Aleksandrova; Antonia Trichopoulou; Eleni Klinaki; Anna Androulidaki; Domenico Palli; Sara Grioni; Carlotta Sacerdote; Rosario Tumino; Salvatore Panico; Marije F Bakker; Guri Skeie; Elisabete Weiderpass; Paula Jakszyn; Aurelio Barricarte; José María Huerta; Esther Molina-Montes; Marcial Argüelles; Ingegerd Johansson; Ingrid Ljuslinder; Timothy J Key; Kathryn E Bradbury; Kay-Tee Khaw; Nicholas J Wareham; Pietro Ferrari; Talita Duarte-Salles; Mazda Jenab; Marc J Gunter; Anne-Claire Vergnaud; Petra A Wark; H B Bueno-de-Mesquita Journal: Int J Cancer Date: 2014-05-14 Impact factor: 7.396